Contents
Current Cancer Drug Targets, Volume 8 - Number 3
The Gene Expression Profiles of Medulloblastoma Cell Lines Resistant to Preactivated Cyclophosphamide
, 8(3): 172 - 179M. D. Bacolod, S. M. Lin, S. P. Johnson, N. S. Bullock, M. Colvin, D. D. Bigner and H. S. Friedman
DOI: 10.2174/156800908784293631
The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications
, 8(3): 187 - 198Amancio Carnero, Carmen Blanco-Aparicio, Oliver Renner, Wolfgang Link and Juan F.M. Leal
DOI: 10.2174/156800908784293659
Circulating Levels of VCAM and MMP-2 May Help Identify Patients with More Aggressive Prostate Cancer
, 8(3): 199 - 206Concetta De Cicco, Laura Ravasi, Laura Zorzino, Maria Teresa Sandri, Edoardo Botteri, Fabrizio Verweij, Donatella Granchi, Ottavio de Cobelli and Giovanni Paganelli
DOI: 10.2174/156800908784293613
Deregulation of the Mitochondrial Apoptotic Machinery and Development of Molecular Targeted Drugs in Acute Myeloid Leukemia
, 8(3): 207 - 222G. Del Poeta, A. Bruno, M. I. Del Principe, A. Venditti, L. Maurillo, F. Buccisano, R. Stasi, B. Neri, F. Luciano, A. Siniscalchi, P. de Fabritiis and S. Amadori
DOI: 10.2174/156800908784293640
Phosphorylation-Specific Prolyl Isomerase Pin1 as a new Diagnostic and Therapeutic Target for Cancer
, 8(3): 223 - 229Greg Finn and Kun Ping Lu
DOI: 10.2174/156800908784293622
Intramammary Application of Non-Methylated-CpG Oligodeoxynucleotides (CpG) Inhibits both Local and Systemic Mammary Carcinogenesis in Female BALB/c Her-2/neu Transgenic Mice
, 8(3): 230 - 242Cristina Mastini, Pablo D. Becker, Manuela Iezzi, Claudia Curcio, Piero Musiani, Guido Forni, Federica Cavallo and Carlos A. Guzman
DOI: 10.2174/156800908784293604
Webmaster Contact: info@benthamscience.org